To study the effects of medication reconciliation and patient counseling on the overall health benefits of the patients in the department of gastroenterology.
INTRODUCTION
Gastroenterology is the study of the normal function and diseases of the esophagus, stomach, small intestine, colon, and rectum, pancreas, gall bladder, bile ducts and liver. In essence, all the normal activities and diseases of the digestive organs are part of the study of gastroenterology [1, 2] .
Patients often receive new medications or have changes made to their existing medications at times of transitions in care-upon hospital admission, transfer from one unit to another during hospitalization, or discharge from the hospital to home or another facility. Although most of these changes are intentional, unintended, changes occur frequently for a variety of reasons. For example, hospital-based clinicians might not be able to easily access the patient's complete pre-admission medication lists, or maybe unaware of recent medication changes. As a result, the new medication regimen prescribed at the time of discharge may inadvertently omit needed medications, unnecessarily duplicate existing therapies, or contain incorrect dosages. These discrepancies place patients at risk for adverse drug events (ADEs), which have been shown to be one of the most common types of adverse events after hospital [3, 4] .
Medication reconciliation refers to the process of avoiding such inadvertent inconsistencies across transitions in care by reviewing the patient's complete medication regimen at the time of admission, transfer, and discharge and comparing it with the regimen being considered for the new setting of care. This reconciliation is done to avoid medication errors such as omissions, duplications, dosing errors and drug interactions. It should be done at every transition of care in which new medications are ordered or existing orders are rewritten [5, 6] .
The National Patient Safety Goal requires the organizations "maintain and communicate accurate medication information" and "compare the medication information the patient brought to the hospital with the medications ordered for the patient by the hospital in order to identify and resolve discrepancies [7, 8] .
Patient counseling refers to the process of providing information, advice and assistance to help patients use their medication appropriately. The information and advice are given by the pharmacist directly to the patients or to the patient's representatives, and may also include information about the patient's illness or recommended lifestyle changes. The information is usually given verbally, but maybe supplemented with written materials. Good communication skills are required to gain the patient's confidence and to motivate the patient to adhere to the recommended regimen [9] [10] [11] .
MATERIALS AND METHODS
The research was a prospective pharmacist interventional study conducted over a period of 8 mo at MNR Hospital, sangareddy, Telangana state after considering the inclusion and exclusion criteria. The sample size was 150 patients and the study population comprised of patients aged 18 y and above. The patient's Best Possible Medication History (BPMH) was taken and the medication reconciliation was done from the patient's case sheet at all interfaces of patient care. The patient involved the study were provided appropriate patient counseling about the disease, drug use and life style changes.
The medication reconciliation process was done in three major steps are a collection of an accurate medication list, clarification of any questions about drug, dose, frequency and communication with physician about any identified queries. clinical care services. No. of Participants in the study were 150 patients and approval Number is IEC/MNRP/Prot/2019/003.
RESULTS AND DISCUSSION
Medication reconciliation process at patient hospitalization, transition and discharge follow up improved medication reconciliation accuracy and care of hospitalized patients led to safer transition to the ambulatory settings. Medication error identification is the main target for improving clinical practice.
The total number of patients involved in our study were 150. The number of male patients were 98 (65.33%) and the number of female patients were 52 (34.67%) and are better illustrated using bar diagram. From the results obtained it was found out that male patients are more prone to the diseases than females in the gastroenterology department during the period of our study. The data was depicted in the form of bar diagram in fig. 1 .
The total number of patients taken were 150. Out of these it was found that about 29 (19.33%) patients are involved with age group of 20-40 y followed by 71 (47.35%) patients are involved in age group of 40-60 y and 50(33.33%) patients in the age group of 60-80 y old. The data was depicted in the form of bar diagram in fig. 2 .
Out of 150 patients, 32(21%) patients were diagnosed with Pancreatitis, 25(17%) patients were diagnosed with Chronic Liver Disease, 25(17%) patients were diagnosed with cholelithiasis, 23(15%) patients were diagnosed with Inflammatory Bowel Disease, 23(15%) patients were diagnosed with other conditions of disease, 8(5%) patients were diagnosed with gastritis, 8(5%) patients were diagnosed with Peptic Ulcer Disease and 6(4%) patients were diagnosed with GERD. Out of these diseases, pancreatitis is more prevalent when compared to other gastrointestinal diseases. The data was depicted in the form of pie diagram of fig. 3 .
From 150 study population, the medication reconciliation was done and found 341 discrepancies from various factors. Among the factors, the drug interactions were found about 167(48.9%), prescribing errors were found to be about 60(7.5%), therapeutic duplications were found to be about 52(15.2%), dosage errors were found to be about 46(13.48%) and omission errors were found to be about 16(4.6%). Out of which the drug interactions were found to be more in prescriptions. The data was depicted in the form of bar diagram in fig. 4 .
The above table shows the type of severity found in the total number of discrepancies in which the moderate type of discrepancies was found to be the highest 183(53.66%). Minor and major discrepancies were 93(27.27%) and 65(19.06%) respectively. The data was tabulated in table no: 5 and depicted in the form of pie diagram in fig. no: 5. The above table shows the type of severity found in the total number of discrepancies in which the moderate type of discrepancies was found to be the highest 183(53.66%). Minor and major discrepancies were 93(27.27%) and 65(19.06%) respectively. The data was tabulated in table 1 and depicted in the form of pie diagram in fig. 5 .
From this table most of the discrepancies found were unintended 274(80.35%) during the course of hospitalization. And the intended discrepancies were 67(19.65%). As unintended discrepancies were more adverse drug events can be reduced significantly. The data was tabulated in table 2.
Out of these, 274 (80.35%) discrepancies in 60 (73.1%) patients are accepted. Followed by 67(19.65%) discrepancies in 15(18.2%) patients are not accepted and 0% of discrepancies in 7(8.5%) patients. Mean and standard deviation found to be 1.90667 and 0.935378 respectively. The data was tabulated in table 3. The number of patients who attended for patient counselling were 150, from which 136(90.66%) patients were cooperative and 14(9.34%) patients were non cooperative. Those who responded were benefitted. The data was depicted in fig. 7 .
We followed a total of 136 patients out of which 100 patients responded to patient counselling, and 36 patients did not respond to patient counselling. Out of the 100 people who responded to patient counselling 86 patients improved their outcome of treatment. From the results it showed that most of the patients were benefitted from patient counselling and improved quality of life. Out of 150 patients, 74 patients received leaflets has counselling aids, 40 patients received pictograms, 34 patients were counselled verbally regarding disease and drug-based condition of the patient for better health care. The data was depicted in the form of bar diagram in fig. 8 .
Clinical pharmacist is responsible to conduct complete medication history and provide information to the patient about the drug therapy which helps to recognize and utilize relevant clinical data to identify and resolve discrepancies such as therapeutic duplication, drug-drug interactions, inappropriate dosaging etc. With appropriate clinical care of patients by a clinical pharmacist could establish a level of attention and disease management which inturn results in better therapeutic outcome [12] . 
Gender wise distribution of cases

CONCLUSION
The basic role of pharmacist, is to help in minimizing the errors and to perform medication reconciliation, which was shown to be an important tool in detecting the medication discrepancies and preventing adverse patient outcomes. Medication reconciliation is performed to avoid medication errors such as omissions, duplication, dosing errors, prescription errors or drug-drug interactions. In our study, the discrepancies were checked and reconciled by which the patient's quality of life was improved and the discrepancies were reduced. As most of discrepancies were accepted by the physician, it helped to resolve the errors.
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